Skip to main content
. 2023 Nov 21;42(12):1391–1402. doi: 10.1200/JCO.22.02912

FIG A1.

FIG A1.

Flowchart of (A) the RC48-C005 trial and (B) the RC48-C009 trial.aFor the C005 study, two patients had two reasons for screening failure. bFor the C009 study, 12 patients had two reasons for screening failure. HER2, human epidermal growth factor receptor 2.